Search the Newsreel

Anmol India Limited Reports Earnings Results for the First Quarter Ended June 30, 2026

Anmol India Q1 Results: Net profit rises 4.9% YoY to ₹6.00 crore

4D Molecular Therapeutics Inc (FDMT) Stock News Today

This article provides current stock information for 4D Molecular Therapeutics Inc (FDMT), noting its recent price dip. It states that more news regarding FDMT's earnings, analyst ratings, and key developments will be available soon. The page serves as a hub for investors to track …

Projeções de Resultados: Colgate-Palmolive Co (CL) — LPA e Crescimento de Receita

Molina Healthcare, Inc $MOH Stake Trimmed by The Manufacturers Life Insurance Company

The Manufacturers Life Insurance Company significantly reduced its stake in Molina Healthcare (NYSE:MOH) by 85.2% in the first quarter, now holding 22,896 shares valued at $3.05 million. This divestment occurred alongside continued insider selling by executives Jeff D. Barlow and Maurice Hebert. Despite these …

Molina Healthcare, Inc $MOH Stake Lifted by Aurora Investment Managers LLC.

Aurora Investment Managers LLC significantly increased its stake in Molina Healthcare, Inc. (NYSE:MOH) by 118.9% in the second quarter, making it their 4th largest position. Other institutional investors also adjusted their holdings. Molina Healthcare reported strong earnings in the last quarter, surpassing analyst estimates, …

Colgate-Palmolive Co (CL) Aktuelle Aktien-News

TSX:TPX.A Dividend Analysis: Is Molson Coors Canada's 4.15% Yield Sustainable?

Molecular Partners AG (MOLN) Aktuelle Aktien-News

Molson Coors Beverage (NYSE:TAP) Posts Earnings Results, Beats Estimates By $0.07 EPS

Colgate-Palmolive (NYSE:CL) Director John Cahill Sells 4,170 Shares

Colgate-Palmolive Director John Cahill sold 4,170 shares of the company's stock for approximately $389,353, reducing his ownership by 12.81%. The company recently reported strong quarterly earnings, beating estimates with $0.99 EPS and revenue of $5.36 billion, and declared a quarterly dividend of $0.53. Analysts …

Molina Healthcare (MOH) Faces A Fair Value Test, Is The Stock Fully Priced?

Molina Healthcare Inc. stock underperforms Friday when compared to competitors despite daily gains

Molina Healthcare Inc. (MOH) stock advanced 2.38% on Friday, closing at $196.45, despite the S&P 500 and Dow Jones Industrial Average also seeing gains. The stock underperformed its competitors and closed 19.78% below its 52-week high of $244.89, achieved on July 14th.

Colgate Palmolive Insider Sold Shares Worth $389,358, According to a Recent SEC Filing

An insider at Colgate Palmolive sold shares valued at $389,358, as per a recent SEC filing. This transaction was reported on August 7, 2026, though specific details of the insider or the nature of the sale were reserved for members of the platform. The …

Molecular Partners AG (MOLN) Earnings Forecast: Future EPS & Revenue Growth Estimates

The article provides an earnings forecast for Molecular Partners AG (MOLN), detailing its current earnings forecast score, average price target, and analyst ratings. Based on 5 analysts, the stock has a "Buy" trend with a target price of $13.62, representing a 220.98% upside. The …

Molson Coors Q2 Earnings Beat Estimates on Pricing and Cost Savings

Insight Molecular Diagnostics Inc. (7OC0.MU) Analyst Insights, Price Targets & Recommendations

This article provides analyst insights, price targets, and recommendations for Insight Molecular Diagnostics Inc. (7OC0.MU). It lists several instances where analysts from Lake Street and Needham have maintained a "Buy" rating for the company's stock between February 2026 and April 2025. The current stock …

4D Molecular Therapeutics Inc (FDMT) Earnings Forecast: Future EPS & Revenue Growth Estimates

4D Molecular Therapeutics Inc expected to post a loss of $1.02 a share - Earnings Preview

4D Molecular Therapeutics Inc (FDMT) is projected to report a loss of $1.02 per share in its upcoming earnings announcement. This information comes from a Refinitiv earnings preview. The article provides a brief outlook on the company's expected financial performance.

Engaging In Options Activity, Noel Wallace Exercises Options Valued At $6.69M In Colgate-Palmolive

Colgate-Palmolive Chairman Noel Wallace exercised stock options for 322,042 shares, valued at $6.69 million, according to a recent SEC filing. The company's financials show positive revenue growth but slower growth compared to industry peers, and its EPS lags the industry average. Colgate-Palmolive maintains a …

Molson Coors Beverage (TAP) Is Seeking Acquisitions For Horizon 2030

Track your investments for FREE with Simply Wall St, the portfolio command center trusted by over 7 million individual investors worldwide. Molson Coors Beverage (NYSE:TAP) is pursuing acquisitions as part of its Horizon 2030 growth strategy. The company plans to invest in growth initiatives …

Sarasin & Partners LLP Cuts Stock Position in Colgate-Palmolive Company $CL

Sarasin & Partners LLP reduced its holdings in Colgate-Palmolive Company by 25.6% in the second quarter, selling 639,036 shares but still retaining a significant stake worth $170.3 million. Despite this, institutional investors collectively own over 80% of the company. Colgate-Palmolive exceeded earnings expectations with …

Mold-Tek Packaging to host investor meet on August 10 in Mumbai

Assenagon Asset Management S.A. Boosts Stock Position in Colgate-Palmolive Company $CL

Assenagon Asset Management S.A. significantly increased its stake in Colgate-Palmolive Company, boosting its holdings by 139.2% in the second quarter. This move makes the firm own approximately 0.21% of Colgate-Palmolive's stock, valued at over $155 million. Other institutional investors also adjusted their positions in …

Molson Coors Beverage Company 2026 Q2 - Results - Earnings Call Presentation (NYSE:TAP) 2026-08-07

Key Points Interested in Molson Coors Beverage Company? Here are five stocks we like better. Molson Coors reaffirmed its fiscal 2026 outlook despite a weak second quarter: constant-currency net sales fell 3.6%, underlying pretax income declined 27.8%, and underlying EPS dropped 22.9% year over …

4D Molecular Therapeutics, Inc. (FDMT) Stock Price, News, Quote & History

This Yahoo Finance page provides comprehensive financial information for 4D Molecular Therapeutics, Inc. (FDMT), a late-stage biotechnology company. It includes real-time stock price, historical data, performance metrics against the S&P 500, analyst ratings,

Should Colgate-Palmolive (CL) Look Fully Valued After Q2 Results And Steady Guidance?

Colgate-Palmolive (NYSE:CL) CEO Sells $14,801,050.32 in Stock

Colgate-Palmolive CEO Noel Wallace sold 161,021 shares of company stock worth approximately $14.8 million. The sale was made to cover tax obligations on vested equity awards, reducing his direct ownership by 30.77%. The company recently reported strong quarterly earnings, beating estimates, and declared a …

Molson Coors Beverage Co (TAP) (Q2 2026) Earnings Call Highlights: Navigating Category ...

This article first appeared on GuruFocus. Release Date: August 06, 2026 For the complete transcript of the earnings call, please refer to the full earnings call transcript. Positive Points Molson Coors Beverage Co (NYSE:TAP) reaffirmed its fiscal 2026 guidance despite external headwinds, demonstrating confidence …

Why Molson Coors Stock Inched Higher Today

Thursday morning, Molson Coors (NYSE: TAP) poured out a quarterly earnings report that was greeted with mild optimism by Mr. Market. Shares of the veteran beer conglomerate rose by slightly over 1% over that day's trading session, in positive contrast to the marginal decline …

Moleculin Biotech (MBRX) stake capped at 4.99% under Intracoastal warrants

A Schedule 13G filing indicates that Mitchell P. Kopin, Daniel B. Asher, and Intracoastal Capital LLC collectively hold a beneficial ownership of 4.99% in Moleculin Biotech, Inc. (MBRX), amounting to 973,927 shares. This ownership includes shares held directly by Intracoastal and shares issuable upon …

COLGATE PALMOLIVE CO SEC Filing (Aug 6, 2026)

This article details a Form 144 SEC filing by Colgate-Palmolive (CL) on August 6, 2026. The filing indicates a proposed sale of 4,170 common shares acquired through the exercise of employee stock options, with an aggregate market value of $389,357.94, to be sold via …

Moleculin Biotech, Inc. (MBRX) CFO buys 293,333 shares and 879,999 warrants

Moleculin Biotech, Inc.'s CFO, Jonathan P. Foster, recently purchased 293,333 shares of common stock and 879,999 Series I Warrants in a public offering. These were acquired at a combined price of $0.75 per unit, with each unit comprising one share and three warrants. Following …

Moleculin Biotech, Inc. (MBRX) CEO adds stock and 1.6M Series I warrants

Moleculin Biotech, Inc.'s CEO, Walter V. Klemp, reported acquiring 533,333 shares of common stock and 1,599,999 Series I warrants in a public offering on August 3, 2026. The purchase was made at a combined price of $0.75 per common share and three accompanying warrants. …

FMR LLC reports 3.6% Molina Healthcare (MOH) stake in updated ownership filing

FMR LLC has filed an amended Schedule 13G, disclosing a beneficial ownership of 1,871,290.18 shares, or 3.6%, of Molina Healthcare Inc. common stock as of June 30, 2026. The filing indicates that FMR LLC holds sole dispositive power over all these shares and sole …

Molson Coors (TAP) Q2 Earnings: Taking a Look at Key Metrics Versus Estimates